Skip to main content
OpenTrials

Clinical trial condition

Urinary Incontinence, Stress

Explore clinical trials studying Urinary Incontinence, Stress. Study availability and eligibility vary by location and protocol.

465 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

Urinary Incontinence, Stress trial results

Completed

To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

NCT00190645

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician Denver, Colorado, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559,1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician Oakville, Ontario, Canada
View Trial Details
Completed

Duloxetine in the Treatment of Stress Urinary Incontinence.

NCT00191087

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. London, England, United Kingdom
View Trial Details
Completed

Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

NCT00191204

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • For additional information regarding investigative sites for this trial contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours EST), or speak with your personal physician. Peterborough, United Kingdom
View Trial Details
Completed

Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.

NCT00190905

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • For additional information regarding investigative sites for this trial, please call 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician Indianapolis, Indiana, United States
View Trial Details
Active, Not Recruiting

Post-Market Clinical Follow-Up onTVT EXACT® Continence System

NCT04829994

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Duke University Durham, North Carolina, United States
  • Institute for Female Pelvic Medicine North Wales, Pennsylvania, United States
  • UPMC Pittsburgh, Pennsylvania, United States
  • Ordensklinikum Linz Linz, Austria
View Trial Details
Active, Not Recruiting

Nationwide Observation Study to Evaluate the Efficacy and Tolerance of the Adjustable Medical Device REMEEX® in the Treatment of Male Stress Urinary Incontinence

NCT03650244

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • CHU de Besançon Besançon, France
  • APHP Hôpital Henry Mondor Créteil, France
  • CHU de Dijon Dijon, France
  • CHU de Limoges Limoges, France
View Trial Details

Related conditions